Status:
COMPLETED
Assessments of Thrombus Formation in TAVI
Lead Sponsor:
Kumamoto University
Conditions:
Aortic Valve Stenosis
Heart Valve Diseases
Eligibility:
All Genders
20-100 years
Brief Summary
Transcatheter aortic valve implantation (TAVI) is well established, and can improve clinical outcomes of patients with severe aortic valve stenosis (AS) who are inoperable or have high surgical risk. ...
Eligibility Criteria
Inclusion
- twenty years and older
- with the informed consent of the patient or support person in case of disability at baseline (patient intubated and ventilated)
Exclusion
- withdrawn the informed consent
- patients with trans-apical approach
- critical illness condition (severe infectious disease, cancer, severe bleeding disorder)
- transition to the surgical AVR
Key Trial Info
Start Date :
August 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2018
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT03248232
Start Date
August 1 2017
End Date
June 30 2018
Last Update
October 2 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kumamoto University Hospital
Kumamoto, Japan, 860-8556